|
Dear
[NAME]
At the Farmavita.Net you can now explore several professional databases which may be helpful for your work:
Public Professional Pharma Databases
This Product Index includes medicines approved in the Member States of the European Union
according to the procedure for Mutual Recognition.
This databases includes medicines approved in the
USA. For innovative products provided is information about data
exclusivity and expiry dates of basic patents. Database is updated
daily.
FDA database of registered drugs.
Database of drugs registered in Russia (Russian Language)
This database enables you to obtain information about manufacturers of active ingredients with European Certficate of Suitability
Excel file with list of all active DMF`s, approved manufacturers and facilities is available for download at repository of Farmavita.Net.
This database enables you to obtain information on a given substance or
general method of analysis. The database contains information such as
the
monograph number, English, French and Latin titles, the state of work,
the
last issue of the Pharmeuropa in which the draft of the monograph was
published, the most recent publication of the text in the European
Pharmacopoeia, whether the monograph is currently undergoing revision,
the
chromatogram in pdf format, and the trade names of some reagents, such
as chromatography columns and biological kits.
According to CFR 314.94(a)(12)(i)(A)(4)
...the applicant shall
provide the patent number and certify, in its opinion and to the best
of its knowledge, ...that the patent is invalid, unenforceable, or will
not be infringed by the manufacture, use, or sale of the drug product
for which the abbreviated application is submitted. The applicant shall
entitle such a certification "Paragraph IV Certification".
Under the Drug Price Competition and Patent Term Restoration Act, or
the Hatch-Waxman Act, a company can seek approval from FDA to market a
generic drug before the expiration of a patent relating to the brand
name drug upon which the generic is based. The first company to submit
an Abbreviated New Drug Application (ANDA) with the FDA has the
exclusive right to market the generic drug for 180 days.
Database with US Petents issued from 1975 until present.
esp@cenet is an
entry-level, internet-based patent document search service offered free
of charge. It provides basic search and retrieval functions on a range
of patent and patent-related documents. As an entry-level service esp@cenet can be a new user's first experience with patent information. For more experienced users, esp@cenet can be a first choice when beginning each new search, before moving on to more sophisticated, professional level, search tools.
Your Subscription:
[SUBSCRIPTIONS]
|
